Literature DB >> 8385105

The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro.

S Giorgetti1, R Ballotti, A Kowalski-Chauvel, S Tartare, E Van Obberghen.   

Abstract

Phosphatidylinositol 3-kinase (PtdIns-3-kinase) is thought to participate in the transductional cascade used by several tyrosine kinase receptors including the insulin-like growth factor (IGF)-I receptor and the insulin receptor. The major insulin receptor cellular substrate IRS-1 (pp185) has been proposed as a possible link between the insulin receptor and PtdIns-3-kinase. In this study we show that both insulin and IGF-I treatment of murine fibroblasts transfected with insulin or IGF-I receptors increase PtdIns-3-kinase activity immunoprecipitated with an antibody directed against the 85-kDa subunit of PtdIns-3-kinase. Whereas only a small amount of PtdIns-3-kinase is found associated with the insulin and IGF-I receptor, a considerable PtdIns-3-kinase activity is immunoprecipitated by an antibody raised against IRS-1. Additionally, insulin and IGF-I stimulation of murine fibroblasts expressing insulin or IGF-I receptors induce tyrosine phosphorylation of IRS-1 and its association with PtdIns-3-kinase. Since IRS-1 seems to be the connection between PtdIns-3-kinase and insulin or IGF-I receptor, we used reconstitution experiments to characterize the implication of IRS-1 in the activation of PtdIns-3-kinase. We show that immunoaffinity-purified IRS-1 can be phosphorylated by ligand-stimulated insulin and IGF-I receptors and that this phosphorylation allows the association of IRS-1 with PtdIns-3-kinase. The interaction between PtdIns-3-kinase and IRS-1 phosphorylated by the insulin or the IGF-I receptor results in the activation of PtdIns-3-kinase. In conclusion, our results demonstrate that IRS-1 is a key component in the signal transduction pathway of PtdIns-3-kinase activation induced by insulin and IGF-I.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385105

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 2.  Signalling through the insulin receptor and the insulin-like growth factor-I receptor.

Authors:  E Van Obberghen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

3.  Correlation of alpha-fetoprotein expression in normal hepatocytes during development with tyrosine phosphorylation and insulin receptor expression.

Authors:  L Khamzina; P Borgeat
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component.

Authors:  R Liu; J N Livingston
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

6.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.

Authors:  K Almind; G Inoue; O Pedersen; C R Kahn
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Transcriptional regulation of the IGF signaling pathway by amino acids and insulin-like growth factors during myogenesis in Atlantic salmon.

Authors:  Neil I Bower; Ian A Johnston
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Anti-insulin growth factor receptor therapy in Ewing sarcoma.

Authors:  Michael S Isakoff; Neyssa Marina
Journal:  F1000 Med Rep       Date:  2009-08-17

10.  Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

Authors:  D N Shapiro; B G Jones; L H Shapiro; P Dias; P J Houghton
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.